Related Subjects:
|Subarachnoid Haemorrhage
|Haemorrhagic stroke
Moyamoya disease is a non-inflammatory vasocclusive disease of the ICA, MCA, and ACA, leading to both ischemic and hemorrhagic stroke. The characteristic net-like vessels seen on cerebral angiograms resemble "moyamoya," a Japanese word for something hazy, like drifting cigarette smoke. The term was popularized by Jiro Suzuki [Suzuki J et al. 1983].
About
- First described in 1957 in Japan as "hypoplasia of the bilateral internal carotid arteries." Named "Moyamoya" in 1965.
- Incidence: 10 per 100,000 in Japan; 1 per 1,000,000 in the USA.
- Increased levels of Basic fibroblast growth factor have been associated with the disease.
- Causes progressive intracranial internal carotid artery occlusion, with fragile collateral vessels that may bleed.
- Both sporadic and familial cases exist, leading to ischemic and hemorrhagic stroke.
Genetics
- Most common in Asians (Japanese, Chinese, and Koreans) but also seen in non-Asian populations.
- Ten times more common in Japanese, Chinese, and Koreans compared to White Europeans and Americans.
- Familial cases are linked to a gene on Chromosome 17.
Aetiology
- Affects distal internal carotid artery, MCA, and ACA stems.
- Leads to extensive collateralization with lenticulostriate and transdural anastomoses between cortical branches of the meningeal and scalp arteries.
- Non-inflammatory; fragile collateral arteries can bleed.
- Similar disease patterns may appear with atherosclerosis and diabetes.
Associations
- Sickle cell disease, beta thalassemia, Neurofibromatosis type I.
- Other associations: Fanconi anemia, hereditary spherocytosis, homocystinuria, APS, Grave's Disease, and SLE.
Clinical Presentation
- Commonly affects young people and may present in childhood.
- Symptoms: recurrent sudden hemiplegia, cognitive impairment, silent infarcts, seizures, chorea, and hemorrhage.
Investigations
- Blood tests are usually unremarkable (non-inflammatory vasculopathy).
- CT Imaging: Shows cortical/subcortical infarction, potential volume loss, and hemorrhages.
- MRI/MRA: Preferred for diagnosis; shows carotid narrowing or occlusion, "puff of smoke" appearance due to fragile collaterals.
- MRI Gradient Echo: Detects hemorrhages and dilated collateral vessels in the basal ganglia and thalamus, known as the "ivy sign" on FLAIR images.
- Transcranial Doppler: Non-invasive evaluation of intracranial hemodynamics and artery stenosis.
- EEG: Characteristic in children with Moyamoya syndrome, showing a "re-build-up phenomenon" after hyperventilation.
- Perfusion Studies: Highlight ischemic areas at risk of infarction.
Stage | Description |
1 | Stenosis of suprasellar ICA, usually bilateral |
2 | Development of Moyamoya vessels with dilation of main cerebral arteries at brain base |
3 | Increasing ICA stenosis, more Moyamoya vessels, reduced flow in MCA and ACA |
4 | Entire Circle of Willis and PCAs occluded; extracranial collateralization with minimized Moyamoya vessels |
5 | Reduced Moyamoya vessels and absence of main cerebral arteries |
6 | Disappearance of Moyamoya vessels; cerebral circulation supplied only by the external carotid system |
Management
- Managed in specialized centers with both medical and surgical options.
- Medical management is largely unproven; includes vasodilators and generally avoiding antiplatelets in older patients.
- Blood pressure management is essential; surgery is generally considered for symptomatic patients.
- Surgical Treatments: Direct bypass (e.g., STA to MCA anastomosis) and indirect methods like multiple burr holes for revascularization. Surgical treatments for Moyamoya can reduce hemorrhagic risk, with recent studies favoring direct approaches.
- Aspirin is used for children but discontinued in adults to reduce bleeding risk.
- Haemorrhagic lesions are the most common cause of death in Moyamoya patients.
Further Reading